Amundi Johnson & Johnson Transaction History

Amundi

$275 Billion
Q4 2024

A detailed history of Amundi transactions in Johnson & Johnson stock. As of the latest transaction made, Amundi holds 11,930,183 shares of JNJ stock, worth $1.84 Billion. This represents 0.63% of its overall portfolio holdings.

Number of Shares

11,930,183

Previous 10,269,725 16.17%

Holding current value

$1.84 Billion

Previous $1.66 Billion 3.67%

% of portfolio

0.63%

Previous 0.63%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$143.34 - $165.86 $238 Million - $275 Million	1,660,458 Added 16.17%	11,930,183 $1.73 Billion
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $110 Million - $127 Million	-756,262 Reduced 6.86%	10,269,725 $1.66 Billion
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $150 Million - $164 Million	1,036,674 Added 10.38%	11,025,987 $1.61 Billion
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $219 Million - $230 Million	1,413,407 Added 16.48%	9,989,313 $1.58 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $378 Million - $412 Million	2,595,089 Added 43.39%	8,575,906 $1.34 Billion
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $150 Million - $168 Million	-964,586 Reduced 13.89%	5,980,817 $932 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $100 Million - $108 Million	650,083 Added 10.33%	6,945,403 $1.15 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $42.5 Million - $50.7 Million	-281,156 Reduced 4.28%	6,295,320 $976 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $81 Million - $91 Million	-505,883 Reduced 7.14%	6,576,476 $1.16 Billion
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $545 Million - $606 Million	3,377,600 Added 91.17%	7,082,359 $1.17 Billion
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $117 Million - $129 Million	694,145 Added 23.06%	3,704,759 $651 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $109 Million - $123 Million	-687,174 Reduced 18.58%	3,010,614 $547 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $123 Million - $136 Million	-787,821 Reduced 17.56%	3,697,788 $624 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $169 Million - $187 Million	-1,044,442 Reduced 18.89%	4,485,609 $724 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $882 Million - $946 Million	5,530,051 New	5,530,051 $911 Million

Others Institutions Holding JNJ

# of Institutions

4,369

Shares Held

1.69B

Call Options Held

16.7M

Put Options Held

13.8M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $403B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account